Evotec AG (NASDAQ:EVTCY) | Finanzwire

Basculer en Français

8296	Companies
114902	Keywords
55328	Articles
62458	Press releases

Home
Companies
Evotec AG

BRIEF

published on 11/14/2024 at 22:56, 6 days 14 hours ago

Evotec SE Responds to Interest from Halozyme

Evotec SE Takeover Halozyme Therapeutics Expression Of Interest EUR 11 Per Share
PRESS RELEASE

published on 11/14/2024 at 22:51, 6 days 14 hours ago

EQS-Adhoc: Comment on media report
Evotec SE receives non-binding expression of interest from Halozyme Therapeutics Inc. for a takeover offer of EUR 11.00 per share

Evotec SE Takeover Offer Expression Of Interest Halozyme Therapeutics Inc. EUR 11.00 Per Share
BRIEF

published on 11/06/2024 at 07:05, 15 days 6 hours ago

Evotec SE Reports Strategic Progress and Revenue Growth Amid Challenges

Strategic Partnerships 2024 Forecasts Biologics Growth Evotec Financial Results Priority Reset Initiative
PRESS RELEASE

published on 11/06/2024 at 07:00, 15 days 6 hours ago

Evotec SE reports 9M 2024 results: Strategic Progress and Successful Expansion Amid Challenging Market Conditions
Evotec SE reports 9M 2024 results with strategic progress amid challenging market conditions. New partnerships and operational milestones achieved

Financial Results Evotec SE Partnerships 9M 2024 Operational Milestones
BRIEF

published on 11/05/2024 at 07:34, 16 days 6 hours ago

Evotec Divests API Manufacturing Facility to Monacum Partners

Evotec Strategic Divestment Monacum Partners API Manufacturing Priority Reset
PRESS RELEASE

published on 11/05/2024 at 07:29, 16 days 6 hours ago

Evotec Announces Sale of API Manufacturing Facility to Monacum Partners
Evotec announces sale of chemical API manufacturing facility to Monacum Partners as part of strategic optimization efforts to focus on key growth areas. Evotec DS in Halle/Westphalia to become DAPIN GmbH under new ownership

Sale Strategic Optimization Evotec Monacum Partners API Manufacturing
BRIEF

published on 10/30/2024 at 08:15, 22 days 5 hours ago

Evotec SE to Release Nine-Month 2024 Financial Results

Financial Results Conference Call Evotec SE Strategic Review Therapeutics Development
PRESS RELEASE

published on 10/30/2024 at 08:10, 22 days 5 hours ago

Evotec SE to announce results for the first nine months 2024 on 06 November 2024
Evotec SE to announce financial results for the first nine months of 2024 on 06 November 2024, including conference call discussing strategic review process

Financial Results Conference Call Evotec SE Life Science Strategic Review
BRIEF

published on 10/23/2024 at 07:34, 29 days 6 hours ago

Evotec and Bristol Myers Squibb Strengthen Proteomics Collaboration

Drug Discovery Bristol Myers Squibb Molecular Glue Degraders Proteomics Partnership Evotec Collaboration
PRESS RELEASE

published on 10/23/2024 at 07:29, 29 days 6 hours ago

Evotec and Bristol Myers Squibb expand proteomics partnership
Evotec SE and Bristol Myers Squibb expand proteomics partnership, advancing molecular glue degraders beyond oncology. Evotec receives US$50m payment

Evotec SE Oncology Bristol Myers Squibb Molecular Glue Degraders Proteomics Partnership

Accesswire

Published on 11/21/2024 at 13:00, 39 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 39 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 39 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 39 minutes ago

Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 39 minutes ago

Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 24 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 4 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 24 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 33 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 39 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 41 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 19 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 54 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 54 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE